153 related articles for article (PubMed ID: 1325829)
1. Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
Br J Cancer; 1992 Sep; 66(3):594-8. PubMed ID: 1325829
[TBL] [Abstract][Full Text] [Related]
2. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
Fizazi K; Cojean I; Pignon JP; Rixe O; Gatineau M; Hadef S; Arriagada R; Baldeyrou P; Comoy E; Le Chevalier T
Cancer; 1998 Mar; 82(6):1049-55. PubMed ID: 9506348
[TBL] [Abstract][Full Text] [Related]
3. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
Jørgensen LG; Hansen HH; Cooper EH
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
Batandier C; Brambilla E; Nagy-Mignotte H; Laporte F; Jacrot M; Beriel H; Paramelle B; Brambilla C
Scand J Clin Lab Invest; 1989 Feb; 49(1):33-42. PubMed ID: 2543057
[TBL] [Abstract][Full Text] [Related]
5. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
[TBL] [Abstract][Full Text] [Related]
6. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
[TBL] [Abstract][Full Text] [Related]
7. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
[TBL] [Abstract][Full Text] [Related]
8. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
[TBL] [Abstract][Full Text] [Related]
9. Neuron-specific enolase during chemotherapy of small cell lung cancer.
Buamah PK; Drake SR; Smedley HM; Bodger WA; Skillen AW
J Surg Oncol; 1990 May; 44(1):1-4. PubMed ID: 2160568
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.
Cooper EH; Splinter TA; Brown DA; Muers MF; Peake MD; Pearson SL
Br J Cancer; 1985 Sep; 52(3):333-8. PubMed ID: 2994704
[TBL] [Abstract][Full Text] [Related]
11. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
[TBL] [Abstract][Full Text] [Related]
12. The prognostic influence of serum neuron specific enolase in small cell lung cancer.
Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
Br J Cancer; 1988 Dec; 58(6):805-7. PubMed ID: 2852029
[TBL] [Abstract][Full Text] [Related]
13. Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice.
Splinter TA; Carney DN; Teeling M; Peake MD; Kho GS; Oosterom R; Cooper EH
J Cancer Res Clin Oncol; 1989; 115(4):400-1. PubMed ID: 2547802
[TBL] [Abstract][Full Text] [Related]
14. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
[TBL] [Abstract][Full Text] [Related]
15. [Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study].
Emin Erbaycu A; Gunduz A; Batum O; Zeren Ucar Z; Tuksavul F; Zeki Guclu S
Arch Bronconeumol; 2010 Jul; 46(7):364-9. PubMed ID: 20537457
[TBL] [Abstract][Full Text] [Related]
16. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.
Niho S; Nishiwaki Y; Goto K; Ohmatsu H; Matsumoto T; Hojo F; Ohe Y; Kakinuma R; Kodama T
Lung Cancer; 2000 Mar; 27(3):159-67. PubMed ID: 10699689
[TBL] [Abstract][Full Text] [Related]
17. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
Akoun GM; Scarna HM; Milleron BJ; Bénichou MP; Herman DP
Chest; 1985 Jan; 87(1):39-43. PubMed ID: 2981171
[TBL] [Abstract][Full Text] [Related]
18. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
Nutini S; Cappelli G; Benucci A; Catalani C; Nozzoli F
Int J Biol Markers; 1990; 5(4):198-202. PubMed ID: 1965544
[TBL] [Abstract][Full Text] [Related]
19. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
Johnson PW; Joel SP; Love S; Butcher M; Pandian MR; Squires L; Wrigley PF; Slevin ML
Br J Cancer; 1993 Apr; 67(4):760-6. PubMed ID: 8385978
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer].
Zhou J; Xiong Q
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):90-3. PubMed ID: 7657349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]